FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Chartier Kirk
2. Issuer Name and Ticker or Trading Symbol

Enova International, Inc. [ ENVA ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Chief Marketing Officer
(Last)          (First)          (Middle)

C/O ENOVA INTERNATIONAL, INC., 175 W. JACKSON BOULEVARD, SUITE 1000
3. Date of Earliest Transaction (MM/DD/YYYY)

2/12/2019
(Street)

CHICAGO, IL 60604
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock, par value $0.00001   2/12/2019     A    24308   (1) (2) A $0.00   106960   (3) D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) with limited SAR   (4) (5) $21.34   2/12/2019     A      52933         (6) 2/12/2026   Common stock, par value $0.00001 per share   52933   $0.00   255077   (7) D    

Explanation of Responses:
(1)  This transaction reflects a grant of Restricted Stock Units ("RSUs") that shall vest in substantially equal one-fourth increments on each of the following dates as long as grantee serves as an employee of Enova International, Inc. ("Issuer") or an affiliate thereof through the applicable vesting date: February 12, 2020, February 12, 2021, February 12, 2022 and February 12, 2023.
(2)  This transaction reflects a grant of time-based Restricted Stock Units ("RSUs") previously granted to the Reporting Person as long as grantee serves as an employee of Enova International, Inc. ("Issuer") or an affiliate thereof. These RSUs were omitted from the Form 4s filed by the reporting person after February 12, 2019.
(3)  Includes timed-based restricted stock units previously granted to the Reporting Person.
(4)  The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
(5)  The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
(6)  The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 12, 2020, February 12, 2021 and February 12, 2022.
(7)  This transaction reflects a grant of stock options ("SOs") previously granted to the Reporting Person as long as grantee serves as an employee of Enova International, Inc. ("Issuer") or an affiliate thereof. These RSUs were omitted from the Form 4s filed by the reporting person after February 12, 2019.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Chartier Kirk
C/O ENOVA INTERNATIONAL, INC.
175 W. JACKSON BOULEVARD, SUITE 1000
CHICAGO, IL 60604


Chief Marketing Officer

Signatures
/s/ Sean Rahilly, attorney-in-fact 5/16/2019
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Enova (NYSE:ENVA)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Enova Charts.
Enova (NYSE:ENVA)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Enova Charts.